Related Experiment Video
Updated: May 11, 2026

Single-Molecule Analysis of Sf9 Purified Superprocessive Kinesin-3 Family Motors
Published on: July 27, 2022
[The advance in synthetic biology: towards a microbe-derived paclitaxel intermediates]
Wei Wang1, Yan Yang, Xiao-Dong Zheng
1State Key Laboratory of Bioactive Substances and Functions of Natural Medicines & Key Laboratory of Biosynthesis of Natural Products, Ministry of Health of PRC, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. wwang@imm.ac.cn
Abstract:
The synthetic biology matures to promote the heterologous biosynthesis of the well-known drug paclitaxel that is one of the most important and active chemotherapeutic agents for the first-line clinical treatment of cancer. This review focuses on the construction and regulation of the biosynthetic pathway of paclitaxel intermediates in both Escherichia coli and Saccharomyces cerevisiae. In particular, the review also features the early efforts to design and overproduce taxadiene and the bottleneck of scale fermentation for producing the intermediates.
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drugs that Stabilize Microtubules
Production of Pharmaceuticals
Bioplastics
Microbial Bioremediation of Plastics
Bioreactor Controls-III
